• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Sale!
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Infectious Disease Molecular Diagnostics Market (Hepatitis, HIV/CT/NG/HPV and Other Tests)

$3,360.00 – $6,720.00

Clear
SKU: KLI15310689 Category: Diagnostics Market Research Pages: 200
  • Description
  • Table of Contents
  • Latest reports

Description

Across the world infectious disease cases are rising, fueling demand for technologies that can detect them.  This report, Infectious Disease Molecular Diagnostics Market, contains market sizing and forecasts for several segments of infectious disease testing:

  • Infectious Disease Market, 2016-2021
  • HPV Diagnostics Market, 2016 to 2021
  •  RSV Diagnostics Market, 2016 to 2021
  •  Mycobacteria/TB Molecular Diagnostics Market, 2016 to 2021
  •  Other Infectious Disease Molecular Diagnostics Market, 2016 to 2021
  • Overall Molecular Diagnostic Market, 2016 to 2021
  • Trends in the Market
  • Market Share for Infectious Disease Molecular Testing Market
  •  NAT Blood Screening Market 2016-2012
  •  Hepatitis Test Market
  •  HIV Diagnostics Market, 2016 to 2021
  •  HAIs/Sepsis Diagnostics Market, 2016 to 2021
  •  CT/NG Diagnostics Market, 2016 to 2021
The report also contains company profiles and detailed product tables and important market trends.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Introduction
  • Overall Molecular Diagnostics Market
  • Molecular Diagnostic Technologies
  • Molecular Diagnostics In Healthcare
  • Global Molecular Diagnostics Market
  • Table 1-1: Global Molecular Diagnostics Market (2016-2021) – Infectious Disease, Blood Screening, Histology, Cancer Assays, Transplant, Inherited Diseases ($ Millions)
  • Figure 1-1: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
  • Conclusions

TWO: INTRODUCTION TO MOLECULAR DIAGNOSTICS

  • Introduction
  • Nucleic Acid Amplification Test (NAAT) Technologies
  • Real-Time Pcr (Qpcr)
  • Isothermal Amplification
  • Table 2-1: Selected Isothermal Amplification Methods And Platform Examples
  • Trends In Nucleic Acid Amplification Testing And Emerging Technologies
  • Microarrays
  • Table 2-2: Selected Clinical Array Component And Microarray Systems

THREE: MOLECULAR DIAGNOSTICS IN HEALTHCARE

  • Introduction
  • Reimbursement Environment for Molecular Diagnostics
  • Molecular Diagnostics And The Clinical Utility Standard
  • Laboratory-Developed Tests Are Here To Stay Conclusions

FOUR: MARKET ANALYSIS

  • Market Size and Forecast by Category
  • Table 4-1: Market-Available Molecular Diagnostic Platforms – POC, Hospital And Developing World (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test PrincipleMarket Analysis
  • Table 4-2: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ Millions)
  • Figure 4-1 Global Molecular Infectious Disease Diagnostics Market (2016) – Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ Millions)
  • Figure 4-2 Global Molecular Infectious Disease Diagnostics Market (2016-2021) – Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ Millions)
  • Table 4-3: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
  • Figure 4-3: Global Molecular Infectious Disease Diagnostics Market (2016) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
  • Figure 4-4: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
  • Figure 4-5: Global Molecular Infectious Disease Diagnostics Market Share – Abbott Diagnostics, BD, Biomérieux, Cepheid, Hologic, Qiagen, Roche Diagnostics, Siemens Healthcare Diagnostics, Others (%)
  • CT/NG, HPV And Women’s Health
  • Hepatitis
  • HIV
  • Hospital-Acquired Infections (HAIs) And Sepsis
  • Respiratory
  • Tuberculosis
  • Market for Molecular Blood Transfusion Diagnostics
    • Introduction
    • Market Analysis
    • Table 4-4: Global NAT Blood Screening (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
    • Figure 4-6: Global NAT Blood Screening Market (2016) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
    • Figure 4-7 Global NAT Blood Screening Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
    • Table 4-5: Commonly Tested Pathogens In Blood Screening
    • Figure 4-8: Global NAT Blood Screening Share – Grifols, Roche Diagnostics, Others (%)
    • New Infectious Disease Threats And Assay Introduction
    • Conclusions

FIVE: COMPANY PROFILES

Abbott Diagnostics

  • Table 5-1: Abbott Diagnostics Revenue (2013-2016) ($ Millions)
  • Infectious Diseases/qPCR
  • Cytogenetics/Oncology/FISH
  • Molecular ID/AST

Agilent Technologies

  • Table 5-2: Agilent Technologies Revenue (Fy 2013-Fy 2016) ($ Millions)
  • Alere
  • Table 5-3: Alere Revenue (2013- 2016) ($ Millions)

Amoy Diagnostics

Beckman Coulter (Danaher)

Becton, Dickinson & Co. (BD)

  • Table 5-4: Becton, Dickinson & Co. (BD) Revenue (Fy 2013-Fy 2016) ($ Millions)
  • Molecular
  • Histology/Cytology
  • Flow Cytometry

Biomérieux

  • Table 5-5: Biomérieux Revenue (2013-2016) ($ Millions)
  • Molecular
  • Sequencing

Bio-Rad Laboratories

  • Transplant Diagnostics
  • Molecular Diagnostic Qc Products
  • Sequencing

Cepheid (Danaher)

  • Table 5-6: Cepheid Revenue (2013-2016) ($ Millions)
  • Molecular Hospital-Acquired Infection (HAI) Testing
  • Molecular Sexual Health And Women’s Health Testing
  • Molecular Critical Infectious Disease Testing
  • Molecular Oncology Testing

Covaris

Eiken Chemical

  • Table 5-7: Eiken Chemical Revenue (Fy 2013-Fy 2016) ($ Millions)

Grifols

  • Table 5-8: Grifols Diagnostic Revenue (2013-2016) ($ Millions)
  • Molecular Immunohematology And Specialty Testing Services
  • NAT Blood Screening

Hologic

  • Table 5-9: Hologic Revenue (Fy 2013-Fy 2016) ($ Millions)
  • Molecular Cytology / Histology (HPV)
  • Other Molecular (Stis, HIV, Hcv, TB, Respiratory)
  • Microbiology (Accuprobe Molecular Culture Id Tests)

Illumina

  • Table 5-10: Illumina Revenue (2013-2016) ($ Millions)
  • Sequencing
  • Translational Research
  • Clinical Assay Development
  • Industry Lab-Developed Tests
  • Arrays

Immucor

  • Table 5-11:Immucor Revenue (Fy 2013-Fy 2016) ($ Millions)
  • Transfusion Diagnostics
  • Transplant Diagnostics
  • Immucor Dx Laboratory Service
  • Janssen Diagnostics (Johnson & Johnson)

Luminex Corporation

  • Table 5-13: Luminex Corporation Revenue (2013- 2016) ($ Millions)
  • Business Expansion
  • Magpix Multiplexing
  • Aries Molecular System

Meridian Bioscience

  • Table 5-14: Meridian Bioscience Revenue (Fy 2013-Fy 2016) ($ Millions)

Qiagen

  • Table 5-15: Qiagen Revenue (2013-2016) ($ Millions)
  • Molecular Infectious Disease
  • Cancer Diagnostics
  • Transplant Diagnostics
  • Next-Generation Sequencing
  • Circulating Tumor Cells

Quidel

  • Table 5-16: Quidel Revenue (2013-2016) ($ Millions)

Roche Diagnostics

  • Table 5-17: Roche Diagnostics Revenue (2013-2016) ($ Millions)
  • Molecular Diagnostics
  • Blood Screening
  • Sequencing
  • Liquid Biopsy
  • Microbiology

Siemens Healthcare Diagnostics

Thermo Fisher Scientific

  • Table 5-18: Thermo Fisher Scientific Revenue (2013-2016) ($ Millions)
  • Transplant Diagnostics
  • PCR
  • Sequencing
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

    $2,625.00 – $5,250.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats, Volumes I – III

    $3,995.00 – $7,990.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other...Retail Clinics 2017: The Game-Changer in Healthcare
Scroll to top